 |
burosumab |
|---|---|
| Trade Name | |
| Orphan Indication | Oncogenic osteomalacia |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-15 00:00:00 |
| Sponsor | Ultragenyx Pharmaceutical Inc.;60 Leveroni Court, Suite 200;Novato, California, 94949 |
| |
burosumab |
|---|---|
| Trade Name | |
| Orphan Indication | Oncogenic osteomalacia |
| USA Market Approval | USA |
| USA Designation Date | 2017-06-15 00:00:00 |
| Sponsor | Ultragenyx Pharmaceutical Inc.;60 Leveroni Court, Suite 200;Novato, California, 94949 |